Welcome to the latest edition of AGHeadlines, providing you with insight every quarter on the latest technologies and tools in women's health helping clinicians deliver exceptional care for women in the UK. In This Edition WEQAS launches a dedicated External Quality Assessment scheme for AmniSure® NHS pilot sites expand for the WID-easy® endometrial cancer test Upcoming conferences and clinical training webinars Limited-time offers across obstetric and neonatal products WEQAS

Recent regulatory scrutiny in Germany has cast a spotlight on misoprostol (Angusta) and its role in labour induction, raising significant safety concerns. As this conversation unfolds across Europe, healthcare professionals are re-evaluating their induction protocols and looking to non-pharmacological methods like DILAPAN-S as a safer alternative.

What activities counts towards your CPD hours? Find links to free learning resources and NMC approved courses in this article.

These 30-minute sessions are hosted by a DILAPAN-S specialist, offering an opportunity to obtain your DILAPAN-S certification.